27th Nov 2012 16:28
The Chairman and Chief Executive of troubled business, translation and communications software company SDL has added 170,532 shares to his stake in the company one day after it issued a profit warning. Mark Lancaster, who also founded the group in 1992, was clearly keen to show his faith in the gr
Read more22nd Oct 2012 08:19
888 Holdings: Morgan Stanley ups target from 125p to 130p, overweight rating kept. Aggreko: Jefferies cuts target from 2,800p to 2,535p, buy rating kept; HSBC downgrades to underweight, target cut from 2,350p to 1,750p; JPMorgan Cazenove cuts target from 2,360p to 2,165p, neutral rating kept; Barcl
Read more19th Oct 2012 16:44
- EU leaders agree to banking supervisor by January - Aggreko and Bunzl lead fallers in London - US heavyweights disappoint with Q3 results The FTSE 100 index had sunk firmly into the red by the close on Friday as investors awaited further news from the European summit. Aggreko and Bunzl were regis
Read more19th Oct 2012 16:02
Hammerson, the property company that has spent much of the year selling off its offices, rose on news that it continues to recycle the cash into shopping centres with the acquisition The Junction Unit Trust. The group has paid £254.5m for the trust, which owns four prominent retail parks in strong
Read more19th Oct 2012 14:58
Support services stocks were firmly in the red on Friday afternoon with Aggreko and Bunzl providing a drag. FTSE 100 temporary power and temperature control group Aggreko sank over 8% after reporting that since its last trading update, exchange rates have "moved against us" and bad debt provisions
Read more19th Oct 2012 11:32
- EU summit in focus - US corporate results disappoint - Aggreko and Bunzl provide a drag on the FTSE 100 The Footsie was slightly lower by Friday lunchtime but was trading within a narrow range of just 19 points as investors awaited further news from the two-day EU summit in Brussels. "The second
Read more19th Oct 2012 09:00
Aggreko: Jefferies keeps buy rating and 2,800p target; Seymour Pierce keeps buy rating and 2,500p target; Panmure Gordon cuts target from 2,228p to 2,159p, hold rating unchanged. Alliance Pharma: umps upgrades to buy, target lifted from 32p to 37p. Avacta: Panmure Gordon keeps buy rating and 1.75p
Read more19th Oct 2012 08:31
- Sentiment dampened by Microsoft and Google - EU summit in focus - Aggreko, Bunzl and financials provide a drag Worse-than-expected results from some US blue chips and the EU summit were in the spotlight on Friday morning, keeping UK stocks flat early on. "European equities are trading lower this
Read more19th Oct 2012 07:24
City sources predict the FTSE 100 will open down 14 points from yesterday's close of 5,917, tracking US stocks lower, which ended Thursday's session firmly in the red following Google's surprise results, which came in well below expectations. Search engine giant Google sent tech stocks into reverse
Read more19th Oct 2012 07:09
Distribution and outsourcing group Bunzl said the third quarter saw a moderation in the underlying revenue growth rate, particularly in North America, where the company is going up against tough comparatives. In the third quarter the underlying growth rate, which strips out the effects of acquisiti
Read more29th Aug 2012 09:38
888 Holdings: Investec upgrades from sell to buy target hiked from 18p to 95p. Advanced Medical Solutions: Singer Capital Markets upgrades to buy, target lifted from 80p to 82p. AstraZeneca: AlphaValue downgrades to reduce. Bunzl: Jefferies raises target from 835p to 860p, underperform rating kep
Read more28th Aug 2012 16:48
- Markets await Jackson Hole symposium - Miners lower on concerns over Japan - Chemring drops after profit warning. Concerns about global economic growth were weighing on sentiment on Tuesday, meaning that the FTSE 100 was little changed by the close despite some volatile swings between gains and
Read more28th Aug 2012 11:47
- Spanish bond auction lifts sentiment - Miners lower on concerns over Japan - Chemring drops profit warning. London's blue-chip index was trading broadly flat by midday, having erased all of the morning's losses, after a solid Spanish bond auction eased concerns about the heavily indebted Eurozone
Read more28th Aug 2012 11:17
UBS has lowered its recommendation for pharmaceuticals giant GlaxoSmithKline from 'buy' to 'neutral', saying that there's limited potential for further upside. "Given GSK's valuation, and somewhat reduced earnings visibility for the stock, we see less scope for performance versus peers, and thereby
Read more28th Aug 2012 10:59
While Investec has maintained its 'hold' rating for distribution and outsourcing group Bunzl, the broker says that company has once again delivered a strong trading performance. Group revenues in the first half came in at £2.61bn and adjusted pre-tax profits were £151.7m, both well ahead of last ye
Read more